Stock listing
Braveheart Bio, Inc.
Selected listing: BRVE · NASDAQ · USD · US
Braveheart Bio, Inc. (NASDAQ:BRVE), Health Technology. Latest release Sep 16, 2026: Braveheart Bio to Participate in Stifel Cardiometabolic Forum.
- Ticker
- NASDAQ:BRVE
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Braveheart Bio, Inc.
Braveheart Bio, Inc. (BRVE) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Braveheart Bio, Inc.
Braveheart Bio to Participate in Stifel Cardiometabolic Forum
September 16, 2026
Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
September 8, 2026
Braveheart Bio to Participate in Cantor Global Healthcare Conference
September 1, 2026
Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 7, 2026
Braveheart Bio Announces Pricing of Upsized Initial Public Offering
August 4, 2026
Research Braveheart Bio, Inc.
Braveheart Bio, Inc. company profile
View the public company page for Braveheart Bio, Inc. on 6ix.
Braveheart Bio, Inc. news
Read company news and market updates connected to Braveheart Bio, Inc..
Braveheart Bio, Inc. investor events
Find investor webinars, events, and replay context for Braveheart Bio, Inc..